Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6150 participants.
Also called NCT04774159
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 6,150 participants
- Registry
-
NCT04774159
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, Brazil, Canada, Ecuador, Germany, Netherlands, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT04774159. Randomized; quadruple masking; primary purpose treatment. Start 2021-05-06 (actual); primary completion 2029-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Acronym
- LEADER-PAD
- Condition
- Peripheral Arterial Disease
- Condition
- Atherosclerosis of Extremities
- Condition
- Inflammation
- Intervention (Drug)
- Colchicine 0.5 MG Oral Tablet
- Intervention (Drug)
- Colchicine-Placebo
- Lead sponsor
- Population Health Research Institute
Record details
- Record id
cardio:ct-nct04774159- Content hash
01080e3992e01387bbd65e416240d88213d68ffb6e91ec436cc4af8bc7b1a4e8